Intuitive Surgical, Inc. completed the acquisition of the da Vinci and Ion distribution business operated by ab medica, Abex, Excelencia Robótica, and their affiliates on March 2, 2026. The transaction brings approximately 250 employees and the full installed base of da Vinci surgical systems in Italy, Spain, and Portugal—over 470 units as of December 31, 2025—under Intuitive’s direct control.
The deal establishes Intuitive’s first direct operations in Italy, Spain, Portugal, Malta, and San Marino, replacing a long‑standing distributor model that had served these markets for more than two decades. By owning the distribution network, Intuitive can provide more responsive customer support, accelerate system placements, and gain deeper insight into local clinical needs.
Intuitive’s Q4 2025 earnings illustrate the financial strength that underpins the acquisition. Revenue rose 19% to $2.87 billion from $2.41 billion in Q4 2024, while GAAP net income increased to $795 million ($2.21 per diluted share) from $686 million ($1.88 per diluted share) in the prior year. Non‑GAAP net income reached $914 million ($2.53 per diluted share) versus $805 million ($2.21 per diluted share) in Q4 2024. The 20.5% year‑over‑year revenue growth was driven by higher procedure volume, increased da Vinci system placements, and a growing installed base of systems.
"Today marks an important step in our commitment to expanding access to proven, safe and effective minimally invasive care to more patients across Europe," said Chief Executive Officer Dave Rosa. "Our direct presence means we are better positioned to meet the needs of our customers in these geographies." "Intuitive is excited to continue to invest in the significant opportunity to bring safe, minimally invasive care to more patients across Europe," said Intuitive CEO Gary Guthart. "Having a direct presence in Italy, Spain, Portugal, Malta, and San Marino, and associated territories allows us to deepen our understanding of unique customer needs in these countries." Dirk Barten, Senior Vice President and General Manager, added, "Intuitive is grateful for the years of strong business and dedication these companies have provided—their leadership has helped establish robotic technology with physicians and their patients in Europe. We look forward to integrating these teams upon deal closure. Developing direct relationships with customers in these countries is critical for building greater patient access to minimally invasive care."
The acquisition aligns with Intuitive’s broader strategy to enhance patient access to minimally invasive surgical options. The company’s financial health remains robust, with a “GREAT” rating of 3.21 out of 5 from Investing.com, and its full‑year 2025 revenue of approximately $10.06 billion represents a 21% increase from 2024. Analysts noted that Intuitive’s shares dipped 1.3% in pre‑market trading following the announcement, reflecting a cautious market response to the transaction’s immediate impact on earnings and cash flow, even as the long‑term benefits of a direct distribution network are expected to strengthen the company’s competitive position in Europe.
Intuitive’s expansion into these key European markets is a strategic milestone that enhances its ability to serve surgeons and patients directly, supports continued revenue growth, and positions the company to capitalize on the growing demand for robotic surgical solutions across the region.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.